The cancer-killing ability of CD8+ T cells (killer T cell) can be stimulated when the T cell receptors (TCRs) recognize cancerous peptide epitopes that are displayed on major histocompatibility complex-I (MHC-I, HLA-I in human) on the surface of the tumor cells. This evidence concerns the gene CD8A and cancer.